UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy

Not Applicable

Completed

Conditions: Chronic HIV Infection

Interventions: Diagnostic Test: POC VL and targeted DRM testing.
Diagnostic Test: SOC VL testing

First Posted Date: 2019-01-29

Last Posted Date: 2024-04-10

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 704

Registration Number: NCT03820323

Locations: 🇰🇪
Rtcp-Faces, Kisumu, Kenya

UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy

Phase 1

Recruiting

Conditions: Alzheimer Disease

Interventions: Drug: [F-18]AV-1451-PET

First Posted Date: 2019-01-18

Last Posted Date: 2024-10-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 160

Registration Number: NCT03809351

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Obesity and Endogenous Oxalate Synthesis

Not Applicable

Active, not recruiting

Conditions: Obesity

Interventions: Dietary Supplement: Normal Individuals

First Posted Date: 2019-01-17

Last Posted Date: 2024-08-12

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 58

Registration Number: NCT03808090

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Smoking Cessation Tailored to Rural Young Adult African American Men:

Not Applicable

Terminated

Conditions: Smoking Cessation

Interventions: Behavioral: TOUCHDOWN
Behavioral: Control Group

First Posted Date: 2019-01-17

Last Posted Date: 2021-05-10

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 35

Registration Number: NCT03808714

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

Phase 1

Recruiting

Conditions: Healthy
Chronic Fatigue Syndrome
Multiple Sclerosis
Fibromyalgia

Interventions: Drug: [Zr-89]Oxine-labeled leukocytes PET/MRI

First Posted Date: 2019-01-17

Last Posted Date: 2024-11-04

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 120

Registration Number: NCT03807973

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS

Not Applicable

Terminated

Conditions: Multiple Sclerosis

Interventions: Behavioral: Behavioral Intervention for Physical Activity in Multiple Sclerosis (BIPAMS)
Behavioral: BIPAMS + Diet

First Posted Date: 2019-01-17

Last Posted Date: 2022-11-18

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 11

Registration Number: NCT03808545

Locations: 🇺🇸
Lakeshore Foundation, Birmingham, Alabama, United States

Enhancing Shared Decision-Making in Breast Cancer

Not Applicable

Completed

Conditions: Shared Decision Making

Interventions: Other: Standard of Care questionnaire
Other: Intervention-specific Carevive questionnaire

First Posted Date: 2019-01-16

Last Posted Date: 2023-01-05

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 140

Registration Number: NCT03806738

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus

Withdrawn

Conditions: Diabetes Mellitus
Sarcoidosis

Interventions: Diagnostic Test: Venous blood sample
Diagnostic Test: Ultrasound of pancreas

First Posted Date: 2019-01-16

Last Posted Date: 2019-12-13

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03805633

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

A Noninvasive Arterial Input Estimation Method for O-15 PET and Integrated PET/MR Scanning

Early Phase 1

Withdrawn

Conditions: Validation of a New Noninvasive Method to Obtain the Arterial Input Function (AIF) Directly by PET Imaging

Interventions: Drug: [O-15]Water
Drug: Acetazolamide

First Posted Date: 2019-01-16

Last Posted Date: 2024-03-01

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03806751

Locations: 🇺🇸
UAB Advanced Imaging Facility, Birmingham, Alabama, United States

Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study

Not Applicable

Active, not recruiting

Conditions: Multiple Sclerosis
Spinal Cord Injuries
Traumatic Brain Injury
Spina Bifida
Stroke
Parkinson Disease
Cerebral Palsy

Interventions: Other: eM2M

First Posted Date: 2019-01-09

Last Posted Date: 2024-10-22

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 108

Registration Number: NCT03797378

Locations: 🇺🇸
UAB Research Collaborative, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy